[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624309":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":27,"locations":36,"responsibleParty":53,"collaborators":10,"id":55,"slug":10,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":61,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":10,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"Participants undergo MRI on study.",[13],"Other: Non-Interventional Study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Non-Interventional Study","Non-interventional study",[9],[20,21],"Non-Interventional Observational Study","Noninterventional (Observational) Study",[23],{"name":24,"affiliation":25,"role":26},"Candice A. Bookwalter, MD, PhD","Mayo Clinic in Rochester","PRINCIPAL_INVESTIGATOR",[28,33],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"Clinical Trials Referral Office","CONTACT","855-776-0015","mayocliniccancerstudies@mayo.edu",{"name":34,"role":30,"phone":35,"phoneExt":10,"email":10},"Bobbie Ott","507-293-0922",[37],{"facility":25,"status":38,"city":39,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Rochester","Minnesota","55905","United States",{"type":44,"coordinates":45},"Point",[46,47],-92.4699,44.02163,{"lat":47,"lon":46},[50,51,52],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},{"name":34,"role":30,"phone":35,"phoneExt":10,"email":10},{"name":24,"role":26,"phone":10,"phoneExt":10,"email":10},{"type":54,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100624309",false,"NCT07407959","Screening and Staging of Benign vs Malignant Pelvic Abnormalities","Clinical Evidence Generation of AI Enabled Fast, Accurate and Precise Screening and Staging of Benign vs Malignant Pelvic Abnormalities","Inclusion Criteria:\n\n* Patient over the age of 18\n* For prostate group, any patient referred for prostate MR for screening purposes with no prior prostate related treatment or prior biopsy\n* For endometriosis group, any patient referred for possible endometriosis evaluation (pre-surgical)\n\nExclusion Criteria:\n\n* Individuals unable to undergo MRI imaging (MR-conditional or MR-nonconditional devices which would need additional procedures\u002Fconditions for scanning, pregnant people, individuals with implanted metal, etc.)\n* Patient under the age of 18\n* Patient who is unable to consent",true,"ALL","18 Years",{"count":65,"type":66},60,"ESTIMATED","OBSERVATIONAL","This study evaluates whether newly developed non-FDA approved image processing techniques \\[Adaptive Image Reconstruction (AIR Recon) Deep Learning (DL) and Sonic DL\\] can provide improved quality and decreased time compared to current scanning techniques.",[70,71],"Endometrial Carcinoma","Prostate Carcinoma","2026-02-12",{"date":74,"type":75},"2026-02-17","ACTUAL",{"date":77,"type":75},"2025-09-04",{"date":79,"type":66},"2028-09-30",{"name":5,"class":6},1]